Compound Detail
CHEMBL2151439
FACINICLINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL2151439 |
| Name | FACINICLINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | TXCYUSKWBHUVEP-CYBMUJFWSA-N |
4
Targets
8
Activities
3
Assay Types
0
PK Parameters
3
Publications
7
Known Names
Molecular Properties
270.3
MW (Da)
1.39
ALogP
3
HBA
2
HBD
61.0
PSA (Ų)
0.87
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Activity Summary
EC50 3 meas. best 6.4
Ki 3 meas. best 8.7
IC50 2 meas. best 8.55
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 3A CHEMBL1899 | Ki | 8.7 | 8.7 | 2.0 | 1 |
| 5-hydroxytryptamine receptor 3A CHEMBL1899 | IC50 | 8.55 | 8.02 | 2.8 | 2 |
| Neuronal acetylcholine receptor subunit alpha-7 CHEMBL2492 | Ki | 8.22 | 8.22 | 6.0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 CHEMBL4980 | Ki | 8.0 | 8.0 | 10.0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 CHEMBL2150833 | EC50 | 6.4 | 6.4 | 400.0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 CHEMBL2492 | EC50 | 6.1 | 5.605 | 800.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21919481 | 10.1021/jm2007672 | Neuronal acetylcholine receptor subunit alpha-7 | 7 |
| 21919481 | 10.1021/jm2007672 | Rattus norvegicus | 4 |
| 21919481 | 10.1021/jm2007672 | 5-hydroxytryptamine receptor 3A | 3 |
Data from ChEMBL 36 via Core Engine